News & Updates
Filter by Specialty:

Poor glycaemic control ups risk of stent failure in T2D patients
Poor glycaemic control appears to contribute to coronary stent failure driven by in-stent restenosis in patients with type 2 diabetes (T2D), suggests a study.
Poor glycaemic control ups risk of stent failure in T2D patients
12 Jul 2024
Real-world data support DOACs over warfarin for VTE
The direct oral anticoagulants (DOACs) apixaban and rivaroxaban trump warfarin for the treatment of venous thromboembolism (VTE) in a retrospective observational analysis comprising real-world VTE patients from Finland, Norway, and Sweden.
Real-world data support DOACs over warfarin for VTE
12 Jul 2024
Statin use tied to joint replacement risk
A French study presented at EULAR 2024 reveals an association between statin treatment and an increased risk of total joint replacement in individuals with knee and hip osteoarthritis (OA).
Statin use tied to joint replacement risk
11 Jul 2024
Statins for primary prevention in the old and very old: Effective and safe
Statins are effective for primary prevention of cardiovascular disease (CVD) and all-cause mortality in individuals aged 75–84 and ≥85 years, and are not associated with significantly increased risks of myopathies and liver dysfunction, according to a target trial emulation conducted using real-world territory-wide electronic health records in Hong Kong.
Statins for primary prevention in the old and very old: Effective and safe
04 Jul 2024
Rural men with erectile dysfunction at greater risk of MACE
Erectile dysfunction (ED) is independently associated with a higher risk of major adverse cardiovascular events (MACE), suggests a study. Moreover, rural men appear to be at greater risk of MACE, with an even higher risk among those with an ED diagnosis.